VRTX logo

VRTX
Vertex Pharmaceuticals, Inc.

12,680
Mkt Cap
$120.48B
Volume
7,594.00
52W High
$519.68
52W Low
$362.50
PE Ratio
30.93
VRTX Fundamentals
Price
$476.24
Prev Close
$474.27
Open
$475.49
50D MA
$466.82
Beta
0.55
Avg. Volume
1.53M
EPS (Annual)
$15.32
P/B
6.45
Rev/Employee
$1.89M
$112,391.78
Loading...
Loading...
News
all
press releases
Teachers Retirement System of The State of Kentucky Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX
Teachers Retirement System of The State of Kentucky lessened its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 37.5% during the third quarter, according to its most...
MarketBeat·56m ago
News Placeholder
More News
News Placeholder
William Blair Investment Management LLC Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX
William Blair Investment Management LLC trimmed its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 97.4% during the third quarter, according to its most...
MarketBeat·57m ago
News Placeholder
The Zacks Analyst Blog Highlights Broadcom, AT&T, Vertex and InterGroup
Broadcom leads today's top research reports as AI chip demand surges, while AT&T and Vertex navigate debt, churn and pipeline risks.
Zacks·5h ago
News Placeholder
Top Research Reports for Broadcom, AT&T & Vertex Pharmaceuticals
Broadcom rides AI chip momentum with VMware gains, while AT&T and Vertex navigate growth plans and key headwinds in latest Zacks reports.
Zacks·17h ago
News Placeholder
Top Biotech Stocks To Watch Now - March 3rd
Danaher, Moderna, and Vertex Pharmaceuticals are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop...
MarketBeat·20h ago
News Placeholder
Victory Capital Management Inc. Buys 92,402 Shares of Vertex Pharmaceuticals Incorporated $VRTX
Victory Capital Management Inc. boosted its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 4.3% during the third quarter, according to its most recent filing with the...
MarketBeat·1d ago
News Placeholder
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Zacks·2d ago
News Placeholder
111 Capital Invests $1.71 Million in Vertex Pharmaceuticals Incorporated $VRTX
111 Capital bought a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The firm bought 4,363...
MarketBeat·2d ago
News Placeholder
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the twenty-seven ratings firms that are presently covering...
MarketBeat·2d ago
News Placeholder
Promising Biotech Stocks To Research - March 1st
Danaher, Vertex Pharmaceuticals, Moderna, argenex, United Therapeutics, ImmunityBio, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·3d ago
<
1
2
...
>

Latest VRTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.